Effects of Teriparatide Treatment and Discontinuation in Postmenopausal Women and Eugonadal Men with Osteoporosis-Reference-Cited by-同舟云学术

Effects of Teriparatide Treatment and Discontinuation in Postmenopausal Women and Eugonadal Men with Osteoporosis

Published:2009-08-01 Issue:8 Volume:94 Page:2915-2921
ISSN:0021-972X
Container-title:The Journal of Clinical Endocrinology & Metabolism
language:en
Short-container-title:

Author:

Leder Benjamin Z.¹,Neer Robert M.¹,Wyland Jason J.¹,Lee Hang W.²,Burnett-Bowie Sherri-Ann M.¹,Finkelstein Joel S.¹

Affiliation:

1. Endocrine Unit, Department of Medicine (B.Z.L., R.M.N., J.J.W., S.M.B., J.S.F.), Massachusetts General Hospital, Boston, Massachusetts 02114

2. Biostatistics Center (H.W.L.), Massachusetts General Hospital, Boston, Massachusetts 02114

Publisher

The Endocrine Society

Subject

Biochemistry, medical,Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism

Link

http://academic.oup.com/jcem/article-pdf/94/8/2915/9065975/jcem2915.pdf

Reference30 articles.

1. Bone health and osteoporosis: a report of the Surgeon General;Washington, DC: U.S. Department of Health and Human Services, Public Health Service, Office of the Surgeon General,2004

2. Parathyroid hormone treatment for osteoporosis.;Cosman;Curr Opin Endocrinol Diabetes Obes,2008

3. Safety of parathyroid hormone for the treatment of osteoporosis.;Miller;Curr Osteoporos Rep,2008

4. Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial.;Black;JAMA,2006

5. Randomized trial of effect of alendronate continuation versus discontinuation in women with low BMD: results from the Fracture Intervention Trial long-term extension.;Ensrud;J Bone Miner Res,2004

Cited by 117 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effect of deprescribing interventions on mortality and health outcomes in older people: An updated systematic review and meta‐analysis;British Journal of Clinical Pharmacology;2024-08-20

2. Abaloparatid – eine neue osteoanabole Therapieoption für die Osteoporose bei postmenopausalen Frauen;Osteologie;2024-07-10

3. Guidelines for fracture risk assessment and management of osteoporosis in postmenopausal women and men above the age of 50 in Qatar;Archives of Osteoporosis;2024-05-02

4. Treatment Sequence for Osteoporosis;Endocrine Practice;2024-05

5. Exerkine FNDC5/irisin‐enriched exosomes promote proliferation and inhibit ferroptosis of osteoblasts through interaction with Caveolin‐1;Aging Cell;2024-04-30